Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...

Nearly 32% of Zepbound users lost at least a quarter of their body weight, compared with about 16% of Wegovy users. In both groups, weight loss was about 6% lower in men than in women, AP said.

The study, which was funded by Lilly, included 751 people from across the U.S. who were overweight or had obesity and at least one other weight-related health problem, but not diabetes.

People taking Eli Lilly's obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk's Wegovy in the first head-to-head study of the blockbuster medications.

Weight-loss Medications May Also Benefit Common Medical Problem, Study Finds The randomized, controlled trial — called SURMOUNT-5 — included 751 people throughout the U.S. and Puerto Rico who ...

(Reuters) -Makers of weight-loss drugs are expected to rake in more than $150 billion in revenue by the early 2030s, thanks ...

Key Takeaways Zepbound helped patients lose 50 pounds, compared to 33 pounds with Wegovy The study showed Zepbound users lost 20% of body weight Both drugs caused some mild stomach-related side ...

Weight-loss Medications May Also Benefit Common Medical Problem, Study Finds The randomized, controlled trial — called SURMOUNT-5 — included 751 people throughout the U.S. and Puerto Rico who ...

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50 percent more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications.